S&P 500 7,718.48 +0.54%
Nasdaq 26,427.65 +0.99%
S&P/TSX 36,090.46 +0.41%
Apple 347.02 +0.90%
Nvidia 217.56 +0.72%
Microsoft 532.67 +0.01%
Shopify 233.31 −1.11%
Royal Bank 284.51 +0.09%
CAD/USD 0.7126 −0.15%
LIVE · 11:35 ET
Market ClerkRecap
Tue Oct 27 · markets open3 signals today140 insider buys this week · $73.9MCIRO short report next: Oct 31The week ahead
GJ
INSIDER · ELVN · Enliven Therapeutics, Inc. · DIRECTOR

Garland J. Scott

Every open-market transaction filed under this name, Oct 1 to Oct 1.

Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$607K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1ELVNEnliven Therapeutics, Inc.DirectorSell13,000$46.67$607K−11.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.